Genavir has chosen Marlink’s integrated maritime health and safety solution XChange Telemed to deliver medical support to crew and scientists on-board five of its ocean-going research vessels.
The vessels include Alis, Antea, L’Atalante, Pourquoi Pas, and Thalassa.
Genavir is the vessel-operating unit of the French Research Institute for Exploitation of the Sea, also known as Ifremer.
The vessels are part of Ifremer’s French Oceanographic Fleet, which are already equipped with Marlink’s Sealink VSAT solution and have been fully integrated with XChange Telemed.
The integration has allowed crew and scientists on-board the vessels to directly communicate with medical experts on shore in case they fall ill or suffer an injury.
Genavir primarily charters or deploys its vessels for two to three months at sea to conduct a scientific mission without a port call.
However, serious medical conditions or injuries on-board force the operator to return to the port, leading to an early end to the scientific mission.
Genavir QHSE Manager Pierre Aldebert said: “By combining live data from the on-board medical kit and patient file with a live video link, XChange Telemed enables professional support from shore for trained medical personnel on-board.
“It will help to diagnose conditions and develop treatments for crew members and scientists, which may enable our ships to remain at sea and complete their mission in the event of illness or injury.”
XChange Telemed combines a vibration-proof hard-case with certified medical equipment for on-board diagnostics by designated medical crew, and a touch-screen user interface and high-definition (HD) camera.
It is linked with Marlink’s XChange communications management platform and Sealink VSAT to stream live video and secure data connection to doctors on shore.